(Q54771328)

English

Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

0 references

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

author name string

Yoshiyuki Morishita

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Shiho Hanawa

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Junko Chinda

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Osamu Iimura

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Sadao Tsunematsu

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Eiji Kusano

6

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

publication date

2 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

34

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

308-313

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

https://scigraph.springernature.com/pub.10.1038/hr.2010.238

0 references

Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Aldosterone blockade in diabetic nephropathy: relative risks and potential promise

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Renin profiling for diagnosis, risk assessment, and treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Racial differences in blood pressure control: potential explanatory factors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

21 January 2018

Plasma Renin Activity and Blood Pressure in Terminal Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

7 January 2021

based on heuristic

inferred from DOI database lookup

C-reactive protein is a strong predictor of mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2010.238

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

release_eqnvho6yp5hztlcidoj3qyn6r4

1 reference

https://api.fatcat.wiki/v0/release/eqnvho6yp5hztlcidoj3qyn6r4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/21124333

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54771328&oldid=1836811592"